SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,551 Cr | ₹1,370 Cr | ₹1,421 Cr | ₹1,413 Cr | ₹1,362 Cr |
What is the latest Revenue of SEQUENT SCIENTIFIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,551 Cr |
| Mar2024 | ₹1,370 Cr |
| Mar2023 | ₹1,421 Cr |
| Mar2022 | ₹1,413 Cr |
| Mar2021 | ₹1,362 Cr |
How is Revenue of SEQUENT SCIENTIFIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,551 Cr | 13.26 | |
| Mar2024 | ₹1,370 Cr | -3.60 | |
| Mar2023 | ₹1,421 Cr | 0.57 | |
| Mar2022 | ₹1,413 Cr | 3.76 | |
| Mar2021 | ₹1,362 Cr | - | |
Compare Revenue of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹4,832.3 Cr | -9.1% | -9.4% | 3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -9.1% |
-9.4% |
3.2% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses